Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EMvision Medical Devices Ltd. ( (AU:EMV) ) has provided an announcement.
EMVision Medical Devices Ltd has announced a Share Purchase Plan (SPP) for its shareholders, allowing them to subscribe for fully paid ordinary shares at a price of A$1.94 per share, with a maximum subscription of A$30,000. Additionally, shareholders who participate in the SPP will be eligible for free-attaching quoted options, exercisable at $3.40 each, expiring two years from the issue date. This initiative is part of the company’s efforts to raise capital and engage its shareholders, potentially impacting its financial stability and market positioning positively.
The most recent analyst rating on (AU:EMV) stock is a Buy with a A$3.15 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Ltd operates in the medical technology industry, focusing on developing and commercializing portable brain imaging technology. The company’s primary product is a portable brain scanner designed to assist in the rapid diagnosis and monitoring of brain injuries and diseases, with a market focus on improving patient outcomes in emergency and clinical settings.
Average Trading Volume: 54,268
Technical Sentiment Signal: Buy
Current Market Cap: A$178.3M
See more data about EMV stock on TipRanks’ Stock Analysis page.